Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination
Clinical trial NCT05422508 · RECRUITING
Trial details
- NCT number
- NCT05422508
- Sponsor
- Green Cross Corporation
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-05
- Primary completion
- 2025-06-01
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.